Aura GT
Aura® GT helps you realize the promise of gene therapies, without using a lot of your viral vector sample throughout the development process. Avoid conditions and formulations that facilitate viral vector aggregates, monitor DNA leakage, and ensure product quality with just 5 µL of sample per data point.
Viral vector aggregation
Receive your quote directly from the manufacturer.
Aura® GT is the first system designed to detect, count, and characterize capsid aggregates and subvisible particles for product quality measurements in gene therapy applications. It also makes it super simple for you to specifically ID capsid from non-capsid aggregates right out of the box and determine if DNA leakage is the source of aggregation.
Aura GT combines Backgrounded Membrane Imaging (BMI) with two channels of Fluorescence Membrane Microscopy (FMM) to give you aggregate data without any clogging concerns or the need to clean between measurements. Get count, size, and morphological information using BMI with full-well imaging and 100% sampling efficiency, or differentiate between cellular, protein, or extrinsic aggregates using FMM to quickly know what’s in your sample.
